Clinical trials sponsored by industry and other private organizations

Differential Globalization of Industry- and Non-Industry–Sponsored Clinical Trials

BACKGROUND Mapping the international landscape of clinical trials may inform global health research governance, but no large-scale data are available. Industry or non-industry sponsorship may have a major influence in this mapping. We aimed to map the global landscape of industry- and non-industry-sponsored clinical trials and its evolution over time. METHODS We analyzed clinical trials initi...

Medical Journals, Academia, and Industry-Sponsored Clinical Trials

Stacia Nordin I appreciate Zlotkin and colleagues’ years of work on the Sprinkle product, and it sounds like the product is much improved from the pill form of micronutrient treatments [1]. I’m not at all opposed to Sprinkle-type products or other nutrient pills for treatment (or in other special situations), but as ten years of international work experience on food and nutrition security issue...

Removing the cloud from industry-sponsored, multicentered clinical trials.

It has been said that laws are imposed on 99% of the population to help prevent the improprieties of the remaining 1%. Although we like to think that the scientific process is exacting, rigorous, and honorable, unfortunately our community also needs oversight. Over the past 4 years as Editor-in-Chief of Blood, I have witnessed an alarming increase in the incidence of scientific misconduct, incl...

Availability of Clinical Trial Data From Industry‐Sponsored Cardiovascular Trials

BACKGROUND Industry-sponsored clinical trials produce high-quality data sets that can be used by researchers to generate new knowledge. We assessed the availability of individual participant-level data (IPD) from large cardiovascular trials conducted by major pharmaceutical companies and compiled a list of available trials. METHODS AND RESULTS We identified all randomized cardiovascular inter...

Physician remuneration in industry-sponsored clinical trials: the case for standardized clinical trial budgets.